These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37709565)

  • 1. Socioeconomic determinants of racial disparities in survival outcomes among patients with renal cell carcinoma.
    Alam R; Rezaee ME; Pallauf M; Elias R; Yerrapragada A; Enikeev D; Fang D; Shariat SF; Woldu SL; Ged YMA; Singla N
    Urol Oncol; 2023 Nov; 41(11):460.e1-460.e9. PubMed ID: 37709565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial disparities in overall survival among renal cell carcinoma patients with young age and small tumors.
    Schwartz K; Ruterbusch JJ; Colt JS; Miller DC; Chow WH; Purdue MP
    Cancer Med; 2016 Feb; 5(2):200-8. PubMed ID: 26710924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Black race may be associated with worse overall survival in renal cell carcinoma patients.
    Anastos H; Martini A; Waingankar N; Paulucci DJ; Beksac AT; Daza J; Patel HV; Gin GE; Sfakianos JP; Badani KK
    Urol Oncol; 2020 Dec; 38(12):938.e9-938.e17. PubMed ID: 32950398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal cell cancer histological subtype distribution differs by race and sex.
    Lipworth L; Morgans AK; Edwards TL; Barocas DA; Chang SS; Herrell SD; Penson DF; Resnick MJ; Smith JA; Clark PE
    BJU Int; 2016 Feb; 117(2):260-5. PubMed ID: 25307281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics.
    Chow WH; Shuch B; Linehan WM; Devesa SS
    Cancer; 2013 Jan; 119(2):388-94. PubMed ID: 23147245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of outcomes for Hispanic and non-Hispanic patients with advanced renal cell carcinoma in the International Metastatic Renal Cell Carcinoma Database.
    Guram K; Huang J; Mouchati C; Abdallah N; Jani C; Navani V; Xie W; El Zarif T; Adib E; Gebrael G; Agarwal N; Li H; Labaki C; Labban M; Ruiz Morales JM; Choueiri TK; Chin Heng DY; Mittal A; Hansen AR; Rose BS; McKay RR
    Cancer; 2024 Jun; 130(11):2003-2013. PubMed ID: 38297953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate of renal cell carcinoma subtypes in different races.
    Sankin A; Cohen J; Wang H; Macchia RJ; Karanikolas N
    Int Braz J Urol; 2011; 37(1):29-32;discussion 33-4. PubMed ID: 21385477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial disparities in renal cell carcinoma: a single-payer healthcare experience.
    Mafolasire A; Yao X; Nawaf C; Suarez-Sarmiento A; Chow WH; Zhao W; Corley D; Hofmann JN; Purdue M; Adeniran AJ; Shuch B
    Cancer Med; 2016 Aug; 5(8):2101-8. PubMed ID: 27228559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial disparity in incidence patterns and outcome of kidney cancer.
    Vaishampayan UN; Do H; Hussain M; Schwartz K
    Urology; 2003 Dec; 62(6):1012-7. PubMed ID: 14665346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial/ethnic disparities in renal cell carcinoma: Increased risk of early-onset and variation in histologic subtypes.
    Batai K; Harb-De la Rosa A; Zeng J; Chipollini JJ; Gachupin FC; Lee BR
    Cancer Med; 2019 Nov; 8(15):6780-6788. PubMed ID: 31509346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic differences between black and white patients implicate a distinct immune response to papillary renal cell carcinoma.
    Paulucci DJ; Sfakianos JP; Skanderup AJ; Kan K; Tsao CK; Galsky MD; Hakimi AA; Badani KK
    Oncotarget; 2017 Jan; 8(3):5196-5205. PubMed ID: 28029648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BAP1 is overexpressed in black compared with white patients with Mx-M1 clear cell renal cell carcinoma: A report from the cancer genome atlas.
    Paulucci DJ; Sfakianos JP; Yadav SS; Badani KK
    Urol Oncol; 2016 Jun; 34(6):259.e9-259.e14. PubMed ID: 26854086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Race and sex disparities in the treatment of older patients with T1a renal cell carcinoma: a comorbidity-controlled competing-risks model.
    Patel HD; Kates M; Pierorazio PM; Allaf ME
    Urol Oncol; 2014 Jul; 32(5):576-83. PubMed ID: 24629500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial disparity in outcomes of a clinical trial population with metastatic renal cell carcinoma.
    Tripathi RT; Heilbrun LK; Jain V; Vaishampayan UN
    Urology; 2006 Aug; 68(2):296-301. PubMed ID: 16904440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Race and renal cell carcinoma stage at diagnosis: an analysis of the Surveillance, Epidemiology, and End Results data.
    Lin J; Kamamia C; Shriver CD; Zhu K
    Eur J Cancer Prev; 2019 Jul; 28(4):350-354. PubMed ID: 30376467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial Disparities and Preventive Measures to Renal Cell Carcinoma.
    Sims JN; Yedjou CG; Abugri D; Payton M; Turner T; Miele L; Tchounwou PB
    Int J Environ Res Public Health; 2018 May; 15(6):. PubMed ID: 29843394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race affects access to nephrectomy but not survival in renal cell carcinoma.
    Zini L; Perrotte P; Capitanio U; Jeldres C; Duclos A; Arjane P; Villers A; Montorsi F; Patard JJ; Karakiewicz PI
    BJU Int; 2009 Apr; 103(7):889-93. PubMed ID: 19021607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial difference in histologic subtype of renal cell carcinoma.
    Olshan AF; Kuo TM; Meyer AM; Nielsen ME; Purdue MP; Rathmell WK
    Cancer Med; 2013 Oct; 2(5):744-9. PubMed ID: 24403240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Food and Drug Administration Approval and Disparities in Immunotherapy Use Among Patients With Cancer in the US.
    Ermer T; Canavan ME; Maduka RC; Li AX; Salazar MC; Kaminski MF; Pichert MD; Zhan PL; Mase V; Kluger H; Boffa DJ
    JAMA Netw Open; 2022 Jun; 5(6):e2219535. PubMed ID: 35771575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding racial disparities in renal cell carcinoma incidence: estimates of population attributable risk in two US populations.
    Callahan CL; Schwartz K; Corley DA; Ruterbusch JJ; Zhao WK; Shuch B; Graubard BI; Rothman N; Chow WH; Silverman DT; Purdue MP; Hofmann JN
    Cancer Causes Control; 2020 Jan; 31(1):85-93. PubMed ID: 31782041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.